Christian Corey Melander

Dr. Christian Corey Melander


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Trends in Biotechnology
Verified
Journal Article
Closed access
RWRoberta J. Worthington
Roberta J. Worthington
CMChristian Corey Melander
Christian Corey Melander

13 May 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MBMary-Catherine Bowman
Mary-Catherine Bowman
TBT. Eric Ballard
T. Eric Ballard
CAChristopher J. Ackerson
Christopher J. Ackerson
DFDaniel L. Feldheim
Daniel L. Feldheim
DMDavid Michael M Margolis
David Michael M Margolis
CMChristian Corey Melander
Christian Corey Melander

13 June 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
RWRoberta J. Worthington
Roberta J. Worthington
JRJustin J. Richards
Justin J. Richards
CMChristian Corey Melander
Christian Corey Melander
Bacterial biofilms are defined as a surface attached community of bacteria embedded in a matrix of extracellular polymeric substances that they have produced. When in the biofilm state, bacteria are more resistant to antibiotics and the host immune response than are their planktonic counterparts. Biofilms are increasingly recognized as being significant in human disease, accounting for 80% of bacterial infections in the body and diseases associated with bacterial biofilms include: lung infections of cystic fibrosis patients, colitis, urethritis, conjunctivitis, otitis, endocarditis and periodontitis. Additionally, biofilm infections of indwelling medical devices are of particular concern, as once the device is colonized infection is virtually impossible to eradicate. Given the prominence of biofilms in infectious diseases, there has been an increased effort toward the development of small molecules that will modulate bacterial biofilm development and maintenance. In this review, we highlight the development of small molecules that inhibit and/or disperse bacterial biofilms through non-microbicidal mechanisms. The review discuses the numerous approaches that have been applied to the discovery of lead small molecules that mediate biofilm development. These approaches are grouped into: (1) the identification and development of small molecules that target one of the bacterial signaling pathways involved in biofilm regulation, (2) chemical library screening for compounds with anti-biofilm activity, and (3) the identification of natural products that possess anti-biofilm activity, and the chemical manipulation of these natural products to obtain analogues with increased activity.

26 May 2017 in ACS Infectious Diseases
Verified
Journal Article
Closed access
RMRoberta J. Melander
Roberta J. Melander
CMChristian Corey Melander
Christian Corey Melander

6 November 2017 in MedChemComm
Verified
Journal Article
Open access
PDF file
RMRoberta Melander
Roberta Melander
DZDaniel V. Zurawski
Daniel V. Zurawski
CMChristian Corey Melander
Christian Corey Melander
While broad spectrum antibiotics play an invaluable role in the treatment of bacterial infections, there are some drawbacks to their use, namely selection for and spread of resistance across multiple bacterial species, and the detrimental effect they can have upon the host microbiome. If the causative agent of the infection is known, the use of narrow-spectrum antibacterial agents has the potential to mitigate some of these issues. This review outlines the advantages and challenges of narrow-spectrum antibacterial agents, discusses the progress that has been made toward developing diagnostics to enable their use, and describes some of the narrow-spectrum antibacterial agents currently being investigated against some of the most clinically important bacteria including Clostridium difficile, Mycobacterium tuberculosis and several ESKAPE pathogens.

26 March 2013 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
RWRoberta J. Worthington
Roberta J. Worthington
CMChristian Corey Melander
Christian Corey Melander